We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+7.02%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.22B
AUM Growth
-$873M
Cap. Flow
-$1.18B
Cap. Flow %
-28.02%
Top 10 Hldgs %
31.05%
Holding
110
New
22
Increased
26
Reduced
27
Closed
30

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$94.6M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$79.4M
3
ZBH icon
Zimmer Biomet
ZBH
+$78.6M
4
DVA icon
DaVita
DVA
+$74.5M
5
HOLX
Hologic
HOLX
+$69M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$103M
2
CNC icon
Centene
CNC
+$85.6M
3
AGN.PRA
Allergan plc
AGN.PRA
+$79.2M
4
JD icon
JD.com
JD
+$78.6M
5
ELV icon
Elevance Health
ELV
+$77.6M

Sector Composition

Rank Sector Weight
1 Healthcare 48.28%
2 Technology 12.7%
3 Communication Services 3.9%
4 Financials 3.09%
5 Consumer Discretionary 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLK icon
76
Blackrock
BLK
$164B
– –
-45,330
Closed -$20.3M
CNC icon
77
CALL
Centene
CNC
$31.8B
– –
-1,432,600
Closed -$69.3M
CNC icon
78
Centene
CNC
$31.8B
– –
-1,768,650
Closed -$85.6M
EVH icon
79
Evolent Health
EVH
$443M
– –
-2,063,033
Closed -$36.7M
GDX icon
80
PUT
VanEck Gold Miners ETF
GDX
$23B
– –
-879,300
Closed -$82.1M
INCY icon
81
PUT
Incyte
INCY
$23.8B
– –
-409,000
Closed -$47.7M
IWM icon
82
iShares Russell 2000 ETF
IWM
$80B
– –
-161,700
Closed -$24M
JD icon
83
JD.com
JD
$41.6B
– –
-2,058,588
Closed -$78.6M
HAPN
84
Happen Inc
HAPN
$2.14B
– –
-326,389
Closed -$9.94M
MDXG icon
85
PUT
MiMedx Group
MDXG
$652M
– –
-981,400
Closed -$11.7M
META icon
86
CALL
Meta Platforms (Facebook)
META
$1.52T
– –
-224,700
Closed -$38.4M
MOH icon
87
CALL
Molina Healthcare
MOH
$10.6B
– –
-490,300
Closed -$33.7M
NTES icon
88
NetEase
NTES
$79.7B
– –
-649,935
Closed -$34.3M
PANW icon
89
Palo Alto Networks
PANW
$259B
– –
-1,604,994
Closed -$38.5M
PFE icon
90
CALL
Pfizer
PFE
$141B
– –
-5,920,529
Closed -$201M
PFE icon
91
Pfizer
PFE
$141B
– –
-1,613,081
Closed -$54.6M
SPGI icon
92
S&P Global
SPGI
$130B
– –
-223,475
Closed -$34.9M
SPY icon
93
State Street SPDR S&P 500 ETF Trust
SPY
$779B
– –
-231,451
Closed -$58.1M
SWKS icon
94
Skyworks Solutions
SWKS
$9.36B
– –
-201,435
Closed -$20.5M
V icon
95
Visa
V
$690B
– –
-190,147
Closed -$20M
VMC icon
96
Vulcan Materials
VMC
$36.9B
– –
-118,745
Closed -$14.2M
VYGR icon
97
Voyager Therapeutics
VYGR
$184M
– –
-397,923
Closed -$8.19M
XBI icon
98
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.3B
– –
-2,126,900
Closed -$184M
XBI icon
99
State Street SPDR S&P Biotech ETF
XBI
$10.3B
– –
-461,125
Closed -$38.6M
CLVS
100
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-220,487
Closed -$18.2M
1 2 3
4
5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q4 2017 Portfolio in Review

As of Q4 2017, PFM Health Sciences held 110 positions worth $4.22B, down 17% from $5.09B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

PFM Health Sciences withdrew a net $1.18B in Q4 2017, closing 30 positions and reducing 27 holdings. Its most notable exit was Centene, an estimated $85.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 33% a quarter earlier, followed by Technology and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Baidu worth $90.7M.

  • PFM Health Sciences's largest Q4 2017 buy was Baidu: 387,046 shares worth $90.7M.
  • PFM Health Sciences added most to Puma Biotechnology in Q4 2017, an estimated $50.6M increase.
  • PFM Health Sciences's biggest Q4 2017 reduction was Meta Platforms (Facebook), cutting an estimated $103M.
  • PFM Health Sciences fully exited Centene in Q4 2017, selling an estimated $85.6M.
  • PFM Health Sciences's ten largest holdings make up 31% of its $4.22B portfolio in Q4 2017.
  • PFM Health Sciences opened 22 new positions and closed 30 in Q4 2017.
  • PFM Health Sciences's portfolio value fell 17% quarter-over-quarter to $4.22B.

Based on PFM Health Sciences's 13F filing for Q4 2017, filed 14 Feb 2018.